Nitrosid (Isosorbide Dinitrate)

Nitrosid (isosorbide dinitrate) is used in the management of cardiovascular conditions that involve myocardial oxygen demand.

• Angina pectoris: decreases the frequency and intensity of exertional chest pain by dilating coronary and peripheral vessels, thereby lowering myocardial oxygen consumption.
• Chronic heart failure: alleviates symptoms such as dyspnea and fatigue by reducing ventricular filling pressures and systemic vascular resistance, which improves cardiac efficiency.
• Acute coronary syndrome (as adjunct therapy): may be added to standard regimens to provide rapid vasodilation and relieve ischemic discomfort while other treatments take effect.

• Isosorbide dinitrate is a pro‑drug that is enzymatically reduced to nitric oxide within vascular smooth‑muscle cells. Nitric oxide activates soluble guanylate cyclase, raising cyclic GMP levels and causing relaxation of smooth muscle in veins and arteries. The resulting reduction in preload and afterload decreases myocardial oxygen demand and enhances cardiac output.

Isosorbide dinitrate may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Headache: throbbing pain often related to vasodilation.
• Flushing: warmth and redness of the skin.
• Dizziness or light‑headedness: especially upon standing.
• Hypotension: low blood pressure causing faintness.
• Nausea: upset stomach, sometimes with vomiting.
• Tachycardia: increased heart rate as a reflex response.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure leading to shock.
• Syncope: sudden loss of consciousness.
• Methemoglobinemia: elevated methemoglobin causing cyanosis.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.

When prescribing or dispensing Nitrosid, several safety considerations should be observed.

• Dose titration: start with low dose and increase gradually to minimize hypotension.
• Concomitant nitrates: avoid using with other nitrate preparations to prevent additive vasodilation.
• Phosphodiesterase‑5 inhibitors: contraindicated due to risk of severe hypotension.
• Cardiovascular status: monitor patients with severe aortic stenosis or recent myocardial infarction closely.
• Pregnancy: category B, use only if benefit outweighs potential risk.
• Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Isosorbide dinitrate can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Other organic nitrates or nitroglycerin: additive vasodilatory effect leading to profound hypotension.
• Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): risk of severe, possibly life‑threatening hypotension.
• Antihypertensive agents (e.g., ACE inhibitors, beta‑blockers) in high doses: may cause excessive blood pressure drop.

Moderate Interactions (Monitor Closely)

• Diuretics: may enhance hypotensive effect, requiring blood pressure monitoring.
• Alcohol: can increase vasodilatory response and dizziness.
• Certain antibiotics (e.g., macrolides) that inhibit CYP enzymes: may raise nitrate levels.